Literature DB >> 17428236

Eliminating the antilipolytic adenosine A1 receptor does not lead to compensatory changes in the antilipolytic actions of PGE2 and nicotinic acid.

S M Johansson1, J-N Yang, E Lindgren, B B Fredholm.   

Abstract

AIM: We examined whether compensatory changes after adenosine A(1) receptor knockout [A(1)R (-/-)] eliminate the antilipolytic actions mediated by this receptor.
METHODS: Lipolysis experiments were performed on adipocytes prepared from the wild type A(1)R (+/+), A(1)R (-/-) and heterozygous mice. Gene expression was assayed with cDNA microarray technique and real-time PCR; protein expression with immunoblotting.
RESULTS: The A(1)R was the only adenosine receptor involved in lipolysis. The effects of adenosine deaminase and 2-chloroadenosine were abolished in A(1)R (-/-) mice. The IC(50) value of 2-chloroadenosine doubled from 16.6 to 33.6 nm when half of the A(1)Rs were eliminated. Adrenergic alpha(2) agonists had no effects on lipolysis. Prostaglandin E(2) (PGE(2)) inhibited lipolysis with an IC(50) value of 5.8 nm (4.7-7.2 nm) in the A(1)R (+/+) mice and 10.6 nm (9.0-12.6 nm) in the A(1)R (-/-) mice. Nicotinic acid inhibited lipolysis with an IC(50) value of 0.30 microm (0.19-0.46 microm) in the A(1)R (+/+) mice and 0.24 microm (0.16-0.37 microm) in the A(1)R (-/-) mice. G(i)alpha(1) mRNA was significantly up-regulated in adipose tissue from A(1)R (-/-) mice. However, immunoblotting showed that G(ialpha1) was not up-regulated at the protein level.
CONCLUSION: The A(1)R mediates the antilipolytic actions of adenosine. Deletion of the A(1)R in mice does not result in compensatory increases in G-protein-mediated antilipolytic actions of PGE(2) or nicotinic acid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428236     DOI: 10.1111/j.1365-201X.2007.01692.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  16 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

2.  Glomerular tubular balance is suppressed in adenosine type 1 receptor-deficient mice.

Authors:  Tracy D Bell; Zaiming Luo; William J Welch
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-01

Review 3.  Adenosine receptors as drug targets.

Authors:  Bertil B Fredholm
Journal:  Exp Cell Res       Date:  2010-02-11       Impact factor: 3.905

Review 4.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

5.  Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice.

Authors:  Min He; Haoran Su; Weiwei Gao; Stina M Johansson; Qing Liu; Xiaoyan Wu; Jiayu Liao; Andrew A Young; Tamas Bartfai; Ming-Wei Wang
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

Review 6.  Adenosine--a physiological or pathophysiological agent?

Authors:  Bertil B Fredholm
Journal:  J Mol Med (Berl)       Date:  2013-12-22       Impact factor: 4.599

7.  Mice heterozygous for both A1 and A(2A) adenosine receptor genes show similarities to mice given long-term caffeine.

Authors:  Jiang-Ning Yang; Olga Björklund; Karin Lindström-Törnqvist; Eva Lindgren; Therese M Eriksson; Johan Kahlström; Jiang-Fan Chen; Michael A Schwarzschild; Irene Tobler; Bertil B Fredholm
Journal:  J Appl Physiol (1985)       Date:  2008-11-26

8.  Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism.

Authors:  Milka Koupenova; Katya Ravid
Journal:  J Cell Physiol       Date:  2013-03-04       Impact factor: 6.384

9.  Impaired glucose tolerance in the absence of adenosine A1 receptor signaling.

Authors:  Robert Faulhaber-Walter; William Jou; Diane Mizel; Lingli Li; Jiandi Zhang; Soo Mi Kim; Yuning Huang; Min Chen; Josephine P Briggs; Oksana Gavrilova; Jurgen B Schnermann
Journal:  Diabetes       Date:  2011-08-10       Impact factor: 9.461

10.  AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency.

Authors:  Kathy Jaworski; Maryam Ahmadian; Robin E Duncan; Eszter Sarkadi-Nagy; Krista A Varady; Marc K Hellerstein; Hui-Young Lee; Varman T Samuel; Gerald I Shulman; Kee-Hong Kim; Sarah de Val; Chulho Kang; Hei Sook Sul
Journal:  Nat Med       Date:  2009-01-11       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.